Terms of use dolor sit amet consectetur, adipisicing elit. Recusandae provident ullam aperiam quo ad non corrupti sit vel quam repellat ipsa quod sed, repellendus adipisci, ducimus ea modi odio assumenda.
Disclaimers
Lorem ipsum dolor sit amet consectetur adipisicing elit. Sequi, cum esse possimus officiis amet ea voluptatibus libero! Dolorum assumenda esse, deserunt ipsum ad iusto! Praesentium error nobis tenetur at, quis nostrum facere excepturi architecto totam.
Lorem ipsum dolor sit amet consectetur adipisicing elit. Inventore, soluta alias eaque modi ipsum sint iusto fugiat vero velit rerum.
Limitation on Liability
Sequi, cum esse possimus officiis amet ea voluptatibus libero! Dolorum assumenda esse, deserunt ipsum ad iusto! Praesentium error nobis tenetur at, quis nostrum facere excepturi architecto totam.
Lorem ipsum dolor sit amet consectetur adipisicing elit. Inventore, soluta alias eaque modi ipsum sint iusto fugiat vero velit rerum.
Copyright Policy
Dolor sit amet consectetur adipisicing elit. Sequi, cum esse possimus officiis amet ea voluptatibus libero! Dolorum assumenda esse, deserunt ipsum ad iusto! Praesentium error nobis tenetur at, quis nostrum facere excepturi architecto totam.
Lorem ipsum dolor sit amet consectetur adipisicing elit. Inventore, soluta alias eaque modi ipsum sint iusto fugiat vero velit rerum.
General
Sit amet consectetur adipisicing elit. Sequi, cum esse possimus officiis amet ea voluptatibus libero! Dolorum assumenda esse, deserunt ipsum ad iusto! Praesentium error nobis tenetur at, quis nostrum facere excepturi architecto totam.
Lorem ipsum dolor sit amet consectetur adipisicing elit. Inventore, soluta alias eaque modi ipsum sint iusto fugiat vero velit rerum.
Join 10k+ people to get notified about new posts, news and tips.
Do not worry we don't spam!
GDPR Compliance
We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.
The pain was getting worse to the point she said it was “taking over my life”;.
After further appointments with medics, she was eventually referred to a consultant and another scan found a mass in her abdomen.
In March 2022 â 18 months after first seeing a GP â she was diagnosed with leiomyosarcoma – soft tissue sarcoma which is a rare, aggressive type of cancer that develops from the connective tissues of the body.
There are only about 525 cases diagnosed annually in England.
Gemma received this horrible news via text message while she was at work.
She said: “I am really frustrated at the way I was treated. If I had been diagnosed earlier, it would have potentially prevented a lot of suffering.
“But I was just fobbed off with painkillers. I was turned away constantly. I was thinking ‘am I going mad?’”;
Gemma was referred to the hospital, and the tumour, which measured 10cm, was removed in May 2022.
The following year, the pains in her back and side returned.
A PET scan in October 2023 revealed she had three new tumours â the cancer was spreading.
Gemma was told her illness was incurable and that she had between 12 and 18 months to live.
On having an incurable illness, she said: “It is difficult to realise this is happening to you, that your body has been taken over by this disease.”;
It is difficult to realise this is happening to you, that your body has been taken over by this disease
Gemma Phillips
Gemma has been documenting her experiences on TikTok @gemphillipsx.
On March 15 this year, five of her friends climbed Mount Snowdon in tribute to “inspirational” Gemma.
One of her five friends that took part in the sponsored climb is Julia Young, 32, from Gloucester.
Julia said: “It’s honestly hard to think about how Gemma's diagnosis has affected me as it just doesn’t feel real. When we meet up it is hard to believe that she is currently fighting this devastating disease.
“She looks so well and she’s always so positive. She is an inspiration to us all and I am in utter awe of her and proud to be her friend.
“Throughout this journey, she has never given up fighting and has lived her life to the full.
Gemma's friends say it's hard to believe she's fighting a disease because she looks so well and it always so positiveGemma was told her illness was incurable and that she had between 12 and 18 months to liveIn tribute to Gemma, five of her friends climbed Mount Snowdon
“She is constantly on the go whether that’s at the stables, out with her friends or going on holiday.
“Even when she was failed by the people who are meant to look after our health, after not diagnosing her with leiomyosarcoma for a year-and-a-half, she hasn’t once shown any anger towards them. 
“She is such a brave person to want to share her story and relive it time and time again by documenting it on her TikTok.”;
The other climbers were Carmela Booth-Williams, Harriet Stevens, Lauren King and Sarah Edmonds.
SarcomaUK’s Director of Research, Policy and Support, Dr Sorrel Bickley, said: “AtSarcomaUK, we've committed over £600,000 to five groundbreaking research projects specifically targeting leiomyosarcoma, the rare cancer affecting Gemma Phillips.
“These studies range from exploring immunotherapy combinations and creating tumour ‘avatars' to investigating the cellular matrix and identifying genetic markers that predict drug effectiveness.
“This research is crucial for patients like Gemma, whose diagnosis was tragically delayed by 18 months.
“Early detection is vital withsarcomas, but equally important is developing effective treatments for patients with advanced disease.
“Our researchers are working to understand drug resistance and identify targeted therapies that could provide better outcomes than standard chemotherapy.
“While these studies won't change Gemma's incurable diagnosis today, they represent our commitment to transforming the future landscape of leiomyosarcoma treatment â potentially extending lives, reducing side effects, and eventually moving toward personalised medicine approaches that match the right treatment to each individual patient.
“Every pound invested brings us closer to better outcomes for the 525 people diagnosed with leiomyosarcoma in England each year.”